Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/14/23 18:21 | 12/12/23 | QNCX | Health | BioPrd | Biological Products, (No Diag | Lamond David | CA | D | 5 | P.m | 602 | 1.20 | 0 | 500 | 8 | 6,686 | M | |||||||||||||||
8/11/23 16:15 | 8/10/23 | QNCX | Health | BioPrd | Biological Products, (No Diag | Thye Dirk | CA | DO | CEO | 2 | P | 210 | 1.25 | 0 | 168 | 60 | 449 | D | ||||||||||||||
8/9/23 18:21 | 8/8/23 | QNCX | Health | BioPrd | Biological Products, (No Diag | Hannah Brendan | CA | O | Chief Bu | 1 | P | 88 | 1.22 | 0 | 72 | 55 | 202 | D | ||||||||||||||
8/9/23 18:18 | 8/8/23 | QNCX | Health | BioPrd | Biological Products, (No Diag | McLoughlin Margaret | CA | D | 1 | P | 10 | 1.23 | 0 | 8 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |